Can we achieve consensus on central venous catheter-related infections?

Anaesthesia and Intensive Care

Volumn 28, Issue 5, 2000, Pages 475-490

  Fraenkel, D J ^a   Rickard, C ^a   Lipman, J ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Infection: central venous catheter, bacteraemia, nosocomial infection

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; MINOCYCLINE; RIFAMPICIN; SULFADIAZINE;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; DISINFECTION; HEALTH CARE COST; HUMAN; IATROGENIC DISEASE; INFECTION PREVENTION; INFECTION RATE; MORBIDITY; MORTALITY; REVIEW; SYMPTOMATOLOGY;

EID: 0033757281     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0002800501     Document Type: Review

References (100)

1. Infectious complications of indwelling vascular catheters
2. Guideline for prevention of intravascular device-related infections
3. Infections caused by intravascular devices used for infusion therapy: Pathogenesis, prevention, and management
4. Secular trends in nosocomial primary bloodstream infections in the United States 1980-1989
5. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection
6. Sepsis associated with central vein catheters in critically ill patients
7. Incidence and predictors of central venous catheter related infection in intensive care patients
8. Prevention of central venous catheter-related bloodstream infection by the use of an antiseptic-impregnated catheter - A randomized controlled trial
9. Prevention of infections associated with vascular catheters
10. Intravascular-catheter-related infections
11. Nosocomial infection rates in adult and pediatric intensive care units in the United States
12. Effect of frequent guidewire changes on triple-lumen catheter sepsis
13. Decreasing catheter-related infection and hospital costs by continuous quality improvement
14. Intravascular catheter associated sepsis: A common problem
15. Infection in central lines: Antiseptic-impregnated vs standard non-impregnated catheters
16. Infections related to medical devices
17. Excess mortality in critically ill patients with nosocomial bloodstream infections
18. Nosocomial bloodstream infection in critically ill patients
19. Perspective: Attributable mortality - The promise of better antimicrobial therapy
20. Nosocomial bloodstream infection in the critically ill
21. Antimicrobial-coated central venous catheters - Icing on the cake or the staff of life?
22. Pathogenesis and prevention of catheter-related septicaemia
23. Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement
24. An evidence-based approach to central venous catheter management to prevent catheter-related infection in critically ill patients
25. Central venous catheter infections: Concepts and controversies
26. Infectious complications of Swan-Ganz pulmonary artery catheters: Pathogenesis, epidemiology, prevention and management
27. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping
28. Novel approach to investigate a source of microbial contamination of central venous catheters
29. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters
30. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion
31. Improved sterile techniquc diminishes the incidence of positive line cultures in cardiovascular patients
32. Pathogenesis of catheter sepsis: A prospective study with quantitative and semiquantitative cultures of catheter hub and segments
33. Hub colonisation as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition
34. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition
35. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates
36. Catheter related infection. A plea for consensus with review and guidelines
37. Central venous catheter replacement strategies: A systematic review of the literature
38. Risk of infection due to central venous catheters: Effect of site of placement and catheter type
39. Infectious and mechanical complications of central venous catheters placed by percutaneous venipuncture and over guidewires
40. An evaluation of triple-lumen catheter infections using a guidewire exchange technique
41. A semiquantitative culture method for identifying intravenous-catheter-related infection
42. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory
43. Definitions for sepsis and multiple organ failure, and guidelines for the use of innovative therapies in sepsis
44. Uniform national numerator definitions for infection control clinical indicators: Surgical site infection and health-care related blood stream infection
45. Diagnosis of catheter-related bacteraemia: A prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures
46. Rapid diagnosis of central venous catheter sepsis
47. A comparison of two antimicrobial-impregnated central venous catheters
48. Risk factors for central venous catheter-related infections in surgical and intensive care units
49. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter related bacteremia
50. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonisation and bloodstream infections
51. Central venous catheter-related infections and their prevention: Is there enough evidence to recommend tunneling for short-term use?
52. Tunneling short-term central venous catheters to prevent catheter-related infection: A meta-analysis of randomised, controlled trials
53. Use of femoral venous catheters in critically ill adults: Prospective study
54. Use of tunneled femoral catheters to prevent catheter-related infection
55. Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters
56. Impact of an educational program for the prevention of colonization of intravascular catheters
57. Cross-sectional epidemiology of phlebitis and catheter-related infections
58. The role of understaffing in central venous catheter-associated bloodstream infections
59. Understaffing: A risk factor for infection in the era of downsizing?
60. Yes, Virginia, aseptic technique is very important: Maximal barrier precautions during insertion reduce the risk of central venous catheter-related bacteraemia
61. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: Implications for catheter management
62. The duration of placement as a predictor of peripheral and pulmonary arterial catheter infections
63. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters
64. A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy
65. Changing subclavian haemodialysis cannulas to reduce infection
66. Catheter-related sepsis: Prospective randomized study of three methods of long term catheter maintenance
67. The relationship between intravenous fluid contamination and the frequency of tubing replacement
68. Safety of changing intravenous delivery systems at longer than 24 hour intervals
69. Intravenous tubing with burettes can be safely changed at 48-hour intervals
70. A prospective study evaluating the effects of extending total parenteral nutrition administration sets to 72 hours
71. Intravenous tubing containing burettes can be safely changed at 72 hours
72. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals; 72 hours is safe and cost effective
73. A randomised trial of 72-hour versus 24-hour intravenous tubing set changes in newborns receiving lipid therapy
74. Bacterial adherence to intravenous catheters and needles and its influence by cannula type and bacterial surface hydrophobicity
75. Colonization of bacteria on polyvinyl chloride and teflon intravascular catheters in hospitalized patients
76. Material thrombogenicity in central venous catheterization: A comparison between soft, antebrachial catheters of silicon elastomer and polyurethane
77. Risk factors for infusion-related phlebitis with small peripheral venous catheters
78. Infusion thrombophlebitis: A prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use
79. Polyurethane and silicone: Myths and misconceptions
80. Role of antimicrobial central venous catheters for the prevention of associated infections
81. The evolving technology of venous access
82. Vascular catheters impregnated with antimicrobial agents: Present knowledge and future direction
83. Reducing the risk for catheter-related infections: A new strategy
84. Benefit of heparin in central venous and pulmonary artery catheters
85. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: Results from a prospective, randomized trial
86. An attachable silver impregnated cuff for the prevention of infection with central venous catheters: A prospective randomized multicenter trial
87. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients
88. Study of a novel antiseptic-coated central venous catheter
89. No difference in catheter sepsis between standard and antiseptic central venous catheters
90. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections
91. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: A randomized controlled trial
92. Anaphylactic shock induced by an antiseptic-coated central venous catheter
93. Severe anaphylactic reaction due to a chlorhexidine-impregnated central venous catheter
94. Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteraemia: Potential role of the combination of minocycline and rifampin
95. Antibiotics and prevention of microbial colonization of catheters
96. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin
97. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters
98. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampicin
99. Retention of anti-bacterial activity and bacterial colonization of antiseptic-bonded central venous catheters
100. Silver iontophoretic catheter: A prototype of a long-term antiinfective vascular access device